Vimarsana
Biggest News Aggregation in the World

Gvoke Kit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gvoke Kit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gvoke Kit Today - Breaking & Trending Today

Xeris Ships One Millionth Gvoke Unit - Vimarsana News

Xeris Ships One Millionth Gvoke Unit

Published: July 31, 2023

31.07.2023 - Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Xeris has ... Seite 1

Source: wallstreet-online.de
Related Topics:
United StatesGvoke HypopenPaulr EdickXeris Biopharma Holdings IncAmerican Diabetes AssociationXeris Biopharma HoldingsXeri ChairmanAmerican DiabetesGvoke Kit
Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript

Published: May 11, 2022

Xeris Biopharma Holdings, Inc. (NASDAQ:NASDAQ:XERS) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Allison Wey - SVP, IR & Corporate Communications Paul...

Source: seekingalpha.com
Related Topics:
United KingdomOren LivnatXeris BiopharmaXeris CareconnectionPiper SandlerPaul EdickAllison WeyDavid AmsellemSteve PieperRoanna RuizSilicon Valley BankCompany ParticipantsCorporate CommunicationsIr Corporate CommunicationsXeris Biopharma Holdings IncXeris Biopharma HoldingsConference Call MayFirst QuarterResults Conference CallSenior Vice PresidentInvestor RelationsSafe HarborPrivate Securities Litigation Reform ActGvoke KitOxford Finance
Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events - Vimarsana News

Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events

Published: May 11, 2022

CHICAGO--(BUSINESS WIRE)--May 11, 2022--

Source: wsiltv.com
Related Topics:
United StatesSan DiegoUnited KingdomAllison WeyXeris BiopharmaStrongbridge BiopharmaXeris CareconnectionPaulr EdickSilicon Valley BankArmistice Capital Master Fund LtdXeris Biopharma Holdings IncCorporate CommunicationsHayfin Capital ManagementOxford FinanceXeris Biopharma HoldingsBiopharma HoldingsGvoke KitQuarter HighlightsSecurities Purchase AgreementArmistice Capital Master FundWainwright Global Investment ConferencePrivate Securities Litigation Reform ActAnnual ReportXeri Annual ReportVice President
Xeris Biopharma Announces Gvoke® Kit Is Now Available for the Treatment of Severe Hypoglycemia in Adults and Children With Diabetes Ages 2 And Above - Vimarsana News

Xeris Biopharma Announces Gvoke® Kit Is Now Available for the Treatment of Severe Hypoglycemia in Adults and Children With Diabetes Ages 2 And Above

Published: March 16, 2022

CHICAGO--(BUSINESS WIRE)--Mar 16, 2022--

Source: wsiltv.com
Related Topics:
United StatesAllison WeyXeris BiopharmaGvoke HypopenKevin MccullochXeris Pharmaceuticals IncXeris Biopharma Holdings IncExchange CommissionCorporate CommunicationsPyramid Laboratories IncXeris Biopharma HoldingsBiopharma HoldingsXeri Chief CommercialGvoke KitPrescribing InformationXeris PharmaceuticalsCosta MesaPrivate Securities Litigation Reform ActXeri Annual ReportInvestor ContactVice PresidentInvestor RelationsBusiness Wire